A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.

Voermans NC, Statland JM, Hayward LJ, Rosenbohm A, López de Munain A, Sacconi S, Leung DG, Badrising UA, Vissing J, Schoser B, Muelas N, Lochmüller H, Bugiardini E, Wang LH, Maggi L, Ragole T, Pestronk A, Hamel JI, Goyal NA, Korngut L, Naddaf E, Harper A, Shieh PB, Kornblum C, Sansone V, Genge A, Tasca G, Jiang J, Jouvin MH, Tawil R, REACH Investigators

Open source

DOI: 10.1177/22143602261419558
Published: 2026 Sep
Container: Journal of neuromuscular diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/22143602261419558,
  title = {A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.},
  author = {Voermans NC and Statland JM and Hayward LJ and Rosenbohm A and López de Munain A and Sacconi S and Leung DG and Badrising UA and Vissing J and Schoser B and Muelas N and Lochmüller H and Bugiardini E and Wang LH and Maggi L and Ragole T and Pestronk A and Hamel JI and Goyal NA and Korngut L and Naddaf E and Harper A and Shieh PB and Kornblum C and Sansone V and Genge A and Tasca G and Jiang J and Jouvin MH and Tawil R and REACH Investigators},
  year = {2026},
  journal = {Journal of neuromuscular diseases},
  doi = {10.1177/22143602261419558},
  url = {https://doi.org/10.1177/22143602261419558}
}

RIS

TY  - JOUR
TI  - A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.
AU  - Voermans NC
AU  - Statland JM
AU  - Hayward LJ
AU  - Rosenbohm A
AU  - López de Munain A
AU  - Sacconi S
AU  - Leung DG
AU  - Badrising UA
AU  - Vissing J
AU  - Schoser B
AU  - Muelas N
AU  - Lochmüller H
AU  - Bugiardini E
AU  - Wang LH
AU  - Maggi L
AU  - Ragole T
AU  - Pestronk A
AU  - Hamel JI
AU  - Goyal NA
AU  - Korngut L
AU  - Naddaf E
AU  - Harper A
AU  - Shieh PB
AU  - Kornblum C
AU  - Sansone V
AU  - Genge A
AU  - Tasca G
AU  - Jiang J
AU  - Jouvin MH
AU  - Tawil R
AU  - REACH Investigators
PY  - 2026
JO  - Journal of neuromuscular diseases
DO  - 10.1177/22143602261419558
UR  - https://doi.org/10.1177/22143602261419558
ER  -

APA

NC, V., JM, S., LJ, H., A, R., A, L. D. M., S, S., DG, L., UA, B., J, V., B, S., N, M., H, L., E, B., LH, W., L, M., T, R., A, P., JI, H., NA, G., L, K., E, N., A, H., PB, S., C, K., V, S., A, G., G, T., J, J., MH, J., R, T., & Investigators, R. (2026). A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.. Journal of neuromuscular diseases. https://doi.org/10.1177/22143602261419558

Source records

pubmed · retrieved 2026-09-27T13:10:26.301Z